Minerva Surgical (Nasdaq:UTRS) announced today that it closed a private placement worth approximately $30 million. Santa Clara, California-based Minerva sold more than 146.6 million shares of its common stock at $0.0246 per share. Accelmed Partners led the private placement with participation by New Enterprise Associates. The financing makes Accelmed the controlling stockholder of Minerva Surgical. […]
Women's Health
Hologic starts the year strongly
Hologic (Nasdaq: HOLX) reported Street-beating first-quarter results, with company officials confident enough to boost full-year revenue and earnings guidance. Revenue from the women’s health and diagnostics company’s COVID-19 assays may be in decline. Plus, there are supply chain challenges related to semiconductor chips in its Breast Health business. Despite the hurdles, sales growth is strong […]
Titan Medical meets with strategic buyers and investors as surgical robot developer considers its future
Titan Medical (Nasdaq:TMDI) met with potential buyers of the surgical robotics company this week in San Francisco. The Toronto-based medical device developer has been considering the best options for investors and the company’s Enos surgical robot. Facing delisting of its stock from the Nasdaq exchange due to its low price last year, Titan Medical announced […]
Hologic expects Q1 revenues, EPS to top prior guidance
Hologic (Nasdaq:HOLX) today announced preliminary first-quarter revenue results for the three months ended Dec. 31, 2022. Marlborough, Massachusetts–based Hologic expects to report revenues of approximately $1.07 billion. That represents a 27% decrease from the same period of the previous year. However, it comes in above Hologic’s guidance range of $940 million to $990 million set […]
Study backs use of Masimo hemoglobin monitoring during cesarean delivery
Masimo (Nasdaq:MASI) today announced positive data from a study of its hemoglobin monitoring for patients undergoing cesarean section. The study observed patients undergoing elective cesarean section (CS) with antepartum hemorrhage. Researchers used noninvasive, continuous hemoglobin monitoring with Masimo SpHb. The study demonstrated significant positive correlations between SpHb and invasive hemoglobin (Hb) values. “In patients undergoing […]
Minerva Surgical CEO retires, former Activ Surgical head Todd Usen named as replacement
Minerva Surgical (Nasdaq:UTRS) announced that it appointed Todd Usen to replace retiring President and CEO David Clapper. Clapper served as president and CEO of the abnormal uterine bleeding (AUB) treatment developer since 2011. Minerva selected Former Activ Surgical CEO Todd Usen to take over those roles and become a member of the board, effective Jan. […]
Movano unveils medical-grade smart ring for women’s health
Movano Health (Nasdaq:MOVE) announced today that it unveiled its Evie smart ring designed specifically for women. Pleasanton, California-based Movano designed Evie to offer intelligence and comfortability in a sleek appearance. It provides users with medical-grade health data for translation into personalized insights delivered through a mobile app. The system requires no monthly subscription, according to […]
Medtronic enrolls first patients in Hugo surgical robot clinical trial
Medtronic (NYSE:MDT) announced today that it enrolled the first patient in its Expand URO U.S. clinical trial for the Hugo surgical robot. Dr. Michael R. Abern at Duke University Hospital (Durham, North Carolina) performed the procedure. He used the Hugo robotic-assisted surgery (RAS) system for a robotic-assisted prostatectomy procedure. “This is an exciting moment,” said Abern. […]
FDA clears RF Medical radiofrequency ablation system
RF Medical announced today that the FDA cleared its Mygen M-3004 generator and specialized electrodes, including Myoblate. The Korea-based thermal ablation system manufacturer made both products commercially available in the U.S. According to a news release, the technologies help to modernize the standard of care for minimally invasive practices. “The world’s medical device market is […]
Olympus launches power morcellator with FDA-advised changes
Olympus today announced the U.S. market launch of its Moresolution power morcellator, saying it supports the safe use of the gynecologic devices under FDA guidance. In 2020, the FDA issued final guidance on power morcellators after the devices faced questions about potentially spreading cancer. The agency recommended limiting laparoscopic power morcellation (LPM) to use with […]
Hologic stock rises on Street-beating Q4 despite continued supply chain challenges
Hologic (Nasdaq:HOLX) shares are up today — a day after fourth-quarter results that came in well ahead of the consensus forecast. Shares of HOLX were up more than 8% at $73.80 apiece by afternoon trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up more than 2%. The […]